靶向MPO的磁性纳米粒子的制备与表征

将表面含有大量氨基的树枝状分子聚酰胺-胺与油溶性的氧化铁纳米粒子(IONPs)进行配体交换,制备了水溶性氧化铁纳米粒子,将动脉粥样硬化斑块中髓过氧化物酶(MPO)的靶向分子5-羟色胺(5-HT)接枝到以树枝状分子为载体的体系上,最后得到树枝状分子包覆IONPs纳米粒子-g-PEG-g-5-羟色胺(5-HTPEG-G3.0@IONPs),可以作为一种靶向动脉粥样硬化斑块的核磁造影成像剂.通过测试产物的红外光谱(FTIR),证明合成了5-HT-PEG-G3.0@IONPs纳米粒子.TEM测试结果表明该纳米粒子的的粒径约为10 nm左右,DLS测试结果显示的粒径约为31.0 nm.利用5-HT具有紫外特征吸收峰(276 nm),确定了终产物中5-HT的接枝量为6.19μg/mg.TGA结果表明5-HT-PEG-G3.0@IONPs的氧化铁含量为2 wt%.VSM测试结果表明该产物具有超顺磁性,且饱和磁化强度为1.47 A·m2/kg.     

PSI-g-PEG-DDA对油溶性超顺磁性氧化铁纳米粒子的包覆及对肿瘤核磁造影成像的研究

天冬氨酸(ASP)自身热缩聚产物聚琥珀酰亚胺(PSI)通过与氨基化聚乙二醇单甲醚(α-胺基-ω-甲氧基-聚乙二醇)和十二胺(DDA)进行连续两步开环反应,制备了双亲性蜈蚣形聚合物聚琥珀酰亚胺接枝聚乙二醇与十二胺(PSI-g-PEG-DDA).随着改变疏水链段DDA的接枝比例,通过胶束粒径的变化确定了最佳的接枝比例.核磁共振波谱(1H-NMR)及凝胶渗透色谱(GPC)对聚合物的性质进行了表征.通过相转移法,聚合物对油溶性超顺磁性氧化铁纳米粒子进行包覆,制备了新型的水溶性超顺磁性氧化铁纳米粒子(PSI-g-PEGDDA@IONPs).动态光散射(DLS)和透射电镜(TEM)对新型的水溶性氧化铁纳米粒子的粒径与形貌进行了表征.体外T2核磁造影成像(MRI in vitro)确定了制备的氧化铁纳米粒子的R2质子驰豫率.肝癌小鼠模型的体内核磁造影成像(MRI in vivo)结果表明新型氧化铁纳米粒子对肿瘤部位有明显的T2核磁造影增强效应,并有很长的体内循环半衰期.以上实验结果表明,新型的水溶性纳米氧化铁粒子可以作为一种潜在的用于肿瘤检测的核磁造影剂.     

靶向髓过氧化酶的双模态探针分子的合成与表征

5-羟色胺(5-HT)对动脉粥样硬化斑块中巨噬细胞分泌的髓过氧化酶(MPO)具有靶向功能,通过酯化反应将5-HT接枝到两亲型聚合物聚衣康酸接枝聚乙二醇接枝十二胺(PIA-g-PEG-g-DDA)上,制备了具有靶向功能的两亲型聚合物(5-HT-g-PIA-g-PEG-g-DDA).采用配体交换法,将超顺磁性氧化铁纳米粒子(SPION)包覆在该聚合物上制备具有磁性的纳米粒子(5-HT-g-PIA-g-PEG-g-DDA@SPION),通过静电力结合使其与碳点(CDs)结合,制备具有荧光成像和核磁造影成像的双模态探针的纳米粒子.采用动态光散射(DLS)及透射电子显微镜(TEM)分析了其粒径和形貌.采用荧光光谱仪与振动样品磁强计(VSM)测试证明该纳米粒子具备双模态成像功能.共聚焦成像(CLSM)的测试结果表明,该纳米试剂对动脉粥样硬化斑块中的巨噬细胞具有靶向性,MTT法的测试结果表明该探针分子具有良好的生物相容性.该双模态探针具有靶向性好、分辨率高及使用便捷的特点,是一种性能优异的双模态检测纳米试剂.     

非共价键自组装制备聚对苯撑乙炔/聚丙烯酸水溶性荧光纳米粒子及其光物理行为研究

通过功能化聚对苯撑乙炔(含羟基与氨基)和聚丙烯酸之间的非共价键自组装制备了一系列含共轭聚合物的水溶性荧光纳米粒子, 并进行了相关结构和光学性质表征. 研究表明, 纳米粒子的大小和聚丙烯酸/聚对苯撑乙炔质量比直接相关. 光物理性质研究表明, 形成水溶性纳米粒子后, 疏水的聚苯撑乙炔链在纳米粒子中易于形成π-链间聚集, 其光物理性质与其在薄膜态时相似.     

环糊精包结络合作用诱导的水溶性聚芴纳米粒子的制备

首先合成了单取代的β环糊精ATRP引发剂(β-CD-Br),利用核磁、质谱等对其进行了表征,并通过ATRP聚合制备了端基为β-环糊精的水溶性聚合物聚甲基丙烯酸N,N-二甲基氨基乙酯(β-CD-PDMAEMA).聚合物β-CD-PDMAEMA可以通过环糊精与金刚烷之间的主客体包结络合作用与端基为金刚烷的聚芴(PFADA)形成水溶性的聚芴纳米粒子.重点探讨了β-CD-PDMAEMA与PF-ADA的质量比和不同的组装方法对纳米粒子尺寸及分布的影响,研究表明质量比为4∶1时通过向2种聚合物的THF混合溶液中缓慢加水的方法可得到流体力学半径(R_h)为80 nm、PDI为0.11的纳米粒子.最后利用透射电子显微镜和原子力显微镜对纳米粒子的形貌进行了表征,进一步依照纳米粒子的R_h随温度升高的实验可以证实纳米粒子具有明显的核壳结构,其中刚性的聚芴为核半径约为50 nm,水溶性的PDMAEMA聚合物为壳.     

二茂铁功能化的水溶性金纳米粒子的合成与表征

以聚乙二醇(PEG)为原料,经4步反应合成了一种端基为二茂铁(FcH)的PEG硫醇配体(Fc-PEG-SH).采用两相法制备了油胺(OAm)保护的金纳米粒子(OAm/nanoAu).采用配体交换法合成了二茂铁功能化的水溶性金纳米粒子(Fc-PEG/nanoAu),其结构和性能经UV-Vis,<'1>H NMR,IR,T...     

配体交换法制备水中高分散稳定性的多羧基修饰Fe3O4纳米颗粒

采用油相高温分解法制备了粒径可控且单分散的油溶性Fe3O4磁性纳米粒子(MNPs-OA), 并通过配体交换对其表面进行了亲水性修饰, 制备了柠檬酸(CA)、 N-(三甲氧基硅丙基)乙二胺三乙酸钠(SiCOOH)、 丁烷四羧酸(BTCA)和乙二胺四乙酸 (EDTA)四钠4种多羧基配体修饰的水溶性Fe3O4磁性纳米粒子(MNPs-CA, MNPs-SiCOOH, MNPs-BTCA 和MNPs-EDTA), 其中首次选用四羧基配体BTCA和EDTA四钠来修饰Fe3O4磁性纳米粒子(MNPs). 对油溶性MNPs和4种水溶性MNPs的形貌、 结构、 化学组成和磁性能进行了表征, 并对4种多羧基配体修饰的水溶性MNPs在水相中的稳定性和分散性进行了表征. 结果表明, 所得MNPs的平均粒径为15 nm, 具有超顺磁性, 配体交换后的水溶性MNPs具有良好的亲水性, 并在弱酸～碱性很宽的pH范围内具备良好的分散稳定性. 此类多羧基修饰的水溶性MNPs可与适当的阳离子聚电解质进行组装, 从而得到在磁靶向载体和磁共振造影(MRI)显影中具有良好应用前景的磁性自组装微囊.     

基于氧化铁纳米材料特性的生物分离和生物检测

氧化铁纳米粒子是一种新型的磁功能材料,被广泛应用于生物、材料以及环境等众多领域.本文介绍了超顺磁氧化铁纳米粒子的制备方法,比较了各种方法的优缺点;评述了磁性氧化铁纳米粒子在细胞、蛋白质和核酸分离及生物检测中的应用,对多功能复合磁性氧化铁纳米粒子的构建, 在生物医学领域中的应用具有的指导意义.     

两亲性壳聚糖衍生物的制备及其包覆量子点

以天然壳聚糖为功能性高分子的骨架,通过西弗碱还原法,以正辛醛和端醛基聚乙二醇单甲基醚(mPEG aldehyde,mPEG-ald)修饰壳聚糖,制备了具有亲疏水性质的N-辛基化-N-mPEG化壳聚糖衍生物(N-octyl-N-mPEG-chitosan,OPEGC),并且以此两亲性壳聚糖衍生物包覆量子点制备了水溶性聚合物量子点纳米粒子.用FTIR、1H-NMR对壳聚糖衍生物进行了结构表征.制备的水溶性胶束,用动态光散射(DLS)测试其流体力学直径与分布,研究了烷基链接枝比率对粒径大小的影响,研究结果表明:烷基链接枝率越高,聚合物胶束粒径越小.以芘为分子探针,通过荧光光谱法测定了壳聚糖衍生物的临界胶束浓度(CMC)为2.032×10-2mg/mL,并对水溶性聚合物量子点纳米粒子进行了紫外、荧光及形貌表征,结果表明得到了荧光发射产率高的聚合物量子点纳米粒子,且尺寸均一、水溶性好.     

P(St-GMA)/Fe3O4磁性聚合物微球的制备及表征

采用沉淀法制备了Fe3O4纳米粒子, 以苯乙烯(St)、甲基丙烯酸缩水甘油酯(GMA)为聚合单体, 使用分散聚合法制备了P(St-GMA)/Fe3O4磁性聚合物微球. 分析了Fe3O4粒子的形貌和结构. 研究了制备条件对磁性聚合物微球磁含量的影响. 采用FTIR, XRD, TG及TEM等手段对磁性聚合物微球的微观结构及形貌、磁含量等进行了分析表征. 研究结果表明, 制备的磁性聚合物微球粒径均一, 磁含量高达74%.     

Synthesis of PAMAM-g-PEG-g-DS-g-RB@IO towards dual-modal imaging in atherosclerosis

This study aimed to synthesize a dual-modal magnetic resonance imaging (MRI)/fluorescence imaging (FLI) nanoprobe in order to detect atherosclerosis. Herein, we had prepared the polyamidoamine-graft-poly (ethylene glycol) (PAMAM-g-PEG) as the carrier. Dextran sulfate (DS) and Rhodamine B (RB) were grafted to PAMAM-g-PEG continuously through reductive amination and amidation reaction to synthesize PAMAM-g-PEG-g-DS-g-RB. The structure of PAMAM-g-PEG-g-DS-g-RB was characterized through nuclear magnetic resonance (¹H-NMR) and Fourier transform infrared spectroscopy (FTIR). A new water-soluble superparamagnetic iron oxide nanoparticles (IONPs) has been synthesized through simple ligand exchange between the iron oxide nanaparticles and PAMAM-g-PEG-g-DS-g-RB. The analysis of transmission electron microscopy (TEM) indicated that micelles were well dispersed in water and had uniform sizes. The result of thermogravimetric analysis (TGA) proved that about 83% (mass fraction) polymers were coated on the surface of IONPs. The MRI in vitro evaluation demonstrated a high R2 value (130.8 mM^?1s^?1) to be served as a T2-weighted contrast agent. The cell counting kit (CCK) assay showed no significant toxicity in RAW264.7. The above results confirmed that PAMAM-g-PEG-g-DS-g-RB@IO could play an significant role of MRI and FLI in the atherosclerosis.     

Polymeric micelles in diagnostic imaging

The results are presented describing the use of polymeric micelles for gamma, magnetic resonance (MR), and computed tomography (CT) imaging. Micelle-forming diacyllipid-PEG conjugates were loaded with monomeric and polymeric amphiphilic chelates, containing entrapped metals, such as 111-In or Gd, and used for the experimental gamma and MR imaging of lymphatics in rabbits. The method is described to prepare polymeric iodine-containing PEG-based micelles which may act as a long-circulating blood pool imaging agent for CT. Experimental CT-imaging performed in mice and rabbits demonstrated high potential of a micellar contrast agent.     

Enhancement of magnetic resonance contrast effect using ionic magnetic clusters

Precise diagnosis by magnetic resonance imaging (MRI) requires sensitive magnetic resonance probes to detect low concentrations of magnetic substances. Ionic magnetic clusters (IMCs) as versatile magnetic probes were successfully synthesized for enhancing the magnetic resonance (MR) contrast effect as well as ensuring high water solubility. IMCs with various sizes were prepared by assembly of MNCs using cationic cetyltrimethylammonium bromide (CTAB) and anionic sodium dodecyl sulfate (SDS). To synthesize IMCs in the aqueous phase, magnetic nanocrystals in an organic solvent were assembled with CTAB and SDS using the nanoemulsion method, to fabricate cationic magnetic clusters (CMCs) and anionic magnetic clusters (AMCs), respectively. IMCs demonstrated ultrasensitivity by MR imaging and sufficient magnetic mobility under an external magnetic field.     

Mesoporous silica-coated hollow manganese oxide nanoparticles as positive T1 contrast agents for labeling and MRI tracking of adipose-derived mesenchymal stem cells

Mesoporous silica-coated hollow manganese oxide (HMnO@mSiO(2)) nanoparticles were developed as a novel T(1) magnetic resonance imaging (MRI) contrast agent. We hypothesized that the mesoporous structure of the nanoparticle shell enables optimal access of water molecules to the magnetic core, and consequently, an effective longitudinal (R(1)) relaxation enhancement of water protons, which value was measured to be 0.99 (mM(-1)s(-1)) at 11.7 T. Adipose-derived mesenchymal stem cells (MSCs) were efficiently labeled using electroporation, with much shorter T(1) values as compared to direct incubation without electroporation, which was also evidenced by signal enhancement on T(1)-weighted MR images in vitro. Intracranial grafting of HMnO@mSiO(2)-labeled MSCs enabled serial MR monitoring of cell transplants over 14 days. These novel nanoparticles may extend the arsenal of currently available nanoparticle MR contrast agents by providing positive contrast on T(1)-weighted images at high magnetic field strengths.     

Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging

A series of core/shell CdSe/Zn1-xMnxS nanoparticles were synthesized for use in dual-mode optical and magnetic resonance (MR) imaging techniques. Mn2+ content was in the range of 0.6-6.2% and varies with the thickness of the shell or amount of Mn2+ introduced to the reaction. These materials showed high quantum yield (QY), reaching 60% in organic solvent. Water-soluble nanoparticles were obtained by capping the core/shell particles with amphiphilic polymer, and the QY values in water reached 21%. These materials also demonstrated high relaxivity with r1 values in the range of 11-18 mM-1 s-1 (at room temperature, 7 T). Both optical and MR imaging were performed on nanoparticles in aqueous solution and applied to cells in culture. The results showed that the QY and manganese concentration in the particles was sufficient to produce contrast for both modalities at relatively low concentrations of nanoparticles.     

Multifunctional Uniform Core–Shell Fe3O4@mSiO2 Mesoporous Nanoparticles for Bimodal Imaging and Photothermal Therapy

Multimodal imaging and simultaneous therapy is highly desirable because it can provide complementary information from each imaging modality for accurate diagnosis and, at the same time, afford an imaging‐guided focused tumor therapy. In this study, indocyanine green (ICG), a near‐infrared (NIR) imaging agent and perfect NIR light absorber for laser‐mediated photothermal therapy, was successfully incorporated into superparamagnetic Fe₃O₄@mSiO₂ core–shell nanoparticles to combine the merit of NIR/magnetic resonance (MR) bimodal imaging properties with NIR photothermal therapy. The resultant nanoparticles were homogenously coated with poly(allylamine hydrochloride) (PAH) to make the surface of the composite nanoparticles positively charged, which would enhance cellular uptake driven by electrostatic interactions between the positive surface of the nanoparticles and the negative surface of the cancer cell. A high biocompatibility of the achieved nanoparticles was demonstrated by using a cell cytotoxicity assay. Moreover, confocal laser scanning microscopy (CLSM) observations indicated excellent NIR fluorescent imaging properties of the ICG‐loaded nanoparticles. The relatively high r₂ value (171.6 mM ^?1 s^?1) of the nanoparticles implies its excellent capability as a contrast agent for MRI. More importantly, the ICG‐loaded nanoparticles showed perfect NIR photothermal therapy properties, thus indicating their potential for simultaneous cancer diagnosis as highly effective NIR/MR bimodal imaging probes and for NIR photothermal therapy of cancerous cells.     

Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging

Maghemite (gamma-Fe2O3) nanocrystals stable at neutral pH and in isotonic aqueous media were synthesized and encapsulated within large unilamellar vesicles of egg phosphatidylcholine (EPC) and distearoyl-SN-glycero-3-phosphoethanolamine-N-[methoxy(poly(ethylene glycol))-2000] (DSPE-PEG(2000), 5 mol %), formed by film hydration coupled with sequential extrusion. The nonentrapped particles were removed by flash gel exclusion chromatography. The magnetic-fluid-loaded liposomes (MFLs) were homogeneous in size (195 +/- 33 hydrodynamic diameters from quasi-elastic light scattering). Iron loading was varied from 35 up to 167 Fe(III)/lipid mol %. Physical and superparamagnetic characteristics of the iron oxide particles were preserved after liposome encapsulation as shown by cryogenic transmission electron microscopy and magnetization curve recording. In biological media, MFLs were highly stable and avoided ferrofluid flocculation while being nontoxic toward the J774 macrophage cell line. Moreover, steric stabilization ensured by PEG-surface-grafting significantly reduced liposome association with the macrophages. The ratios of the transversal (r2) and longitudinal (r1) magnetic resonance (MR) relaxivities of water protons in MFL dispersions (6 < r2/r1 < 18) ranked them among the best T2 contrast agents, the higher iron loading the better the T2 contrast enhancement. Magnetophoresis demonstrated the possible guidance of MFLs by applying a magnetic field gradient. Mouse MR imaging assessed MFLs efficiency as contrast agents in vivo: MR angiography performed 24 h after intravenous injection of the contrast agent provided the first direct evidence of the stealthiness of PEG-ylated magnetic-fluid-loaded liposomes.     

Facile preparation of zwitterion-stabilized superparamagnetic iron oxide nanoparticles (ZSPIONs) as an MR contrast agent for in vivo applications

We describe a simple method for synthesizing superparamagnetic nanoparticles (SPIONs) as small, stable contrast agents for magnetic resonance imaging (MRI) based on sulfobetaine zwitterionic ligands. SPIONs synthesized by thermal decomposition were coated with zwitterions to impart water dispersibility and high in vivo stability through the nanoemulsion method. Zwitterion surfactant coating layers are formed easily on oleic acid-stabilized SPIONs via hydrophobic and van der Waals interactions. Our zwitterion-coated SPIONs (ZSPIONs) had ultrathin (～5 nm) coating layers with mean sizes of 12.0 ± 2.5 nm, as measured by dynamic light scattering (DLS). Upon incubation in 1 M NaCl and 10% FBS, the ZSPIONs showed high colloidal stabilities without precipitating, as monitored by DLS. The T2 relaxivity coefficient of the ZSPIONs, obtained by measuring the relaxation rate on the basis of the iron concentration, was 261 mM(-1) s(-1). This value was much higher than that of the commercial T2 contrast agent because of the ultrathin coating layer. Furthermore, we confirmed that ZSPIONs can be used as MR contrast agents for in vivo applications such as tumor imaging and lymph node mapping.     

Iron oxide/MCM-41 mesoporous nanocomposites and their magnetorheology

Mesoporous nanocomposite materials of magnetic iron oxide-containing MCM-41 (IO/MCM-41) were prepared by simple thermal oxidation of Fe-containing MCM-41 initially prepared by a direct synthesis route using Fe³⁺ salt. The magnetic saturation of the fabricated nanocomposite materials was measured using a vibrating sample magnetometer, while surface morphology and inner framework of the composite materials were studied using a field emission scanning electron microscope and a transmission electron microscope to confirm their mesoporous nanocomposite formation. The fabricated magnetic materials were then adopted as a magnetorheological (MR) fluid, where the IO/MCM-41 magnetic nanocomposites were dispersed in a nonmagnetic medium oil in addition to as an additive for carbonyl iron-based MR fluid. Their MR properties of flow curve along with yield stress and viscoelastic properties under applied magnetic fields were investigated using a rotational rheometer.     

Manganese-based MRI contrast agents: past, present and future

Paramagnetic and superparamagnetic metals are used as contrast materials for magnetic resonance (MR) based techniques. Lanthanide metal gadolinium (Gd) has been the most widely explored, predominant paramagnetic contrast agent until the discovery and association of the metal with nephrogenic systemic fibrosis (NSF), a rare but serious side effects in patients with renal or kidney problems. Manganese was one of the earliest reported examples of paramagnetic contrast material for MRI because of its efficient positive contrast enhancement. In this review, manganese based contrast agent approaches are discussed with a particular emphasis on their synthetic approaches. Both small molecules based typical blood pool contrast agents and more recently developed novel nanometer sized materials are reviewed focusing on a number of successful molecular imaging examples.